Kos Biotech Fund Invests €111M in Crete Hub, Targets Four Deals by 2026
Published 1 d ago1 sourceEvidence: Reported
Versant Ventures and Eli Lilly, with other investors, committed $100 million to a new startup focused on solving a key gene therapy challenge, likely delivery or immunogenicity. The funding signals continued private-sector investment in gene therapy infrastructure, though the specific technical approach and clinical timeline remain undisclosed. This matters as it could accelerate solutions to a bottleneck limiting gene therapy's broader application.
AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works
Entities
Published 1 d ago1 sourceEvidence: Reported
Published 1 d ago1 sourceEvidence: Reported
Published 3 d ago2 sourcesEvidence: Reported
Published 2 d ago2 sourcesEvidence: Reported
Published 3 d ago2 sourcesEvidence: Reported
Published 14 h ago1 sourceEvidence: Reported
Published 2 d ago3 sourcesEvidence: Reported
Published 1 d ago2 sourcesEvidence: Reported